From: JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients
Patients (nr) | Median VLa | Median VL (IQR)b | |
---|---|---|---|
PBMCs | 4/24* | 3 x 102 | 2.45 (2.28-3.11) |
serum | 4/24#† | 3.75 x 103 | 3.53 (3.11-3.82) |
urine | 11/24*† | 4.1 x 105 | 5.60 (5.08-5.84) |